07/31/2025
7:57 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2025
6:34 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:31 PM | MILLENNIUM MANAGEMENT LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
06/16/2025
8:10 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2025
8:40 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
4:35 PM | DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:35 PM | Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:36 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:34 PM | Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
4:34 PM | Honore Tage (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
6:01 AM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for VNDA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vanda Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
05/21/2025
8:23 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
6:06 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
3:31 PM | Vanda Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2025
3:33 PM | Vanda Pharmaceuticals (Filer)
| Form DEFA14A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
03/17/2025
8:15 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2025
4:53 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:46 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:44 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:45 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:30 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:13 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
6:38 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
6:04 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
7:21 PM | Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:43 PM | Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:44 PM | Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
6:45 PM | Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:46 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
12:40 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
12:23 PM | BlackRock, Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/27/2025
7:22 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:45 PM | Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:07 AM | Vanda Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024
7:00 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
4:00 PM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:10 AM | Vanda Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
MarketBeat All Access